Tech Company Financing Transactions
Tokai Pharmaceuticals Funding Round
Queensland Investment Corporation joined a $9.3 million capital raise for Tokai Pharmaceuticals . The round was announced on 6/30/2007.
Transaction Overview
Company Name
Announced On
6/30/2007
Transaction Type
Venture Equity
Amount
$9,264,900
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
255 State St. 6th floor
Boston, MA 02109
USA
Boston, MA 02109
USA
Phone
Website
Email Address
Not Recorded
Overview
Tokai Pharmaceuticals (NASDAQ: TKAI) develops biopharmaceutical products that focus on endocrine treatment. The company is developing novel, proprietary therapies for prostate cancer and other hormonally-driven diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jodie Morrison
Chief Operating Officer
John McBride
Browse more venture capital transactions:
Prev: 6/30/2007: MongoNet venture capital transaction
Next: 6/30/2007: 3point5.com venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs